-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

661.P1.18 661. Malignant Stem and Progenitor Cells: Poster I

Malignant Stem and Progenitor Cells Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Caroline Pabst, M.D.1,2*, Anne Bergeron, PhD3*, Vincent-Philippe Lavallée, M.D.4, Jonathan Yeh, PhD5*, Patrick Gendron, M.Sc2*, Jana Krosl, PhD6*, Geneviève Boucher, M.Sc2*, Sébastien Lemieux, Ph.D.2,7*, Josee Hébert, MD8,9,10,11, Guy Sauvageau, M.D., Ph.D.2,9,12 and Frédéric Barabé, MD13,14,15

1Martin-Luther-University of Halle-Wittenberg, Department of Internal Medicine IV- Hematology and Oncology, Halle (Saale), Germany
2The Leucegene project at Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
3Centre de Recherche du CHU de Québec, Centre de Recherche en Infectiologie, Quebec City, Canada
4Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada
5University of Montreal, Institute for Research in Immunology and Cancer, Montreal, Canada
6IRIC/Unv. de Montreal Faculty of Medicine, Montreal, QC, Canada
7Department of Computer Science and Operations Research, Université de Montréal, Montréal, QC, Canada
8Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, QC, Canada
9Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada
10Hematology-Oncology Division, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
11Quebec Leukemia Cell Bank, Montréal, QC, Canada
12Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada
13Centre de Recherche du CHU de Québec, Centre de Recherche en Infectiologie, Québec, Canada
14CHU de Québec, Hopital Enfant-Jésus, Québec, Canada
15Department of Medicine, Université Laval, Québec, Canada

John M. Perry, PhD1, Anuradha Roy2*, Xiuling Lu, PhD3*, Xi C. He, MD1, Fang Tao1*, Meng Zhao, PhD4, Pengxu Qian, PhD1 and Linheng Li, PhD1

1Stowers Institute for Medical Research, Kansas City, MO
2Shankel Structural Biology Center, University of Kansas, Lawrence, KS
3Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT
4Stowers Institute For Medical Research, Kansas City, MO

Turan Aghayev1*, Chun Zhou, PhD1*, Alyssa Klein2*, Esteban Martinez1*, Claudia Scholl3, Stefan Fröhling3 and Stephen Matthew Sykes, PhD1

1Fox Chase Cancer Center, Philadelphia, PA
2Columbia University College of Physicians and Surgeons, Columbia University Medical Center, New York City, NY
3National Center for Tumor Diseases, Heidelberg, Germany

David Spencer, MD/PhD1, Daniel R. George2*, Jeffery M. Klco, MD/PhD3 and Timothy J. Ley, MD4

1Division of Oncology, Department of Internal Medicine, Washington University in St. Louis School of Medicine, St. Louis, MO
2Division of Oncology, Washington University School of Medicine, St. Louis, MO
3St Jude Children's Research Hospital, Memphis, TN
4Washington University School of Medicine, St. Louis, MO

Gabriel Pineda, PhD1*, Kathleen M Lennon, BS1*, Nathaniel P Delos-Santos, BS1*, Florence Lambert-Fliszar1*, Gennarina L Riso, BS2*, Marco A Marra, PhD3, Sheldon Morris, MD4*, Asako Sakaue-Sawano, PhD5*, Atsushi Miyawaki, PhD5* and Catriona HM Jamieson, MD, PhD6

1Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center, University of California San Diego, La Jolla, CA
2Biological Sciences Department, California Polytechnic State University, San Luis Obispo, CA
3Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
4Department of Medicine, University of California, San Diego, La Jolla, CA
5Brain Science Institute, RIKEN, Wako-city, Japan
6Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA

Zeena Salman, MD, MPH1*, Juan Carlos Balandrán-Juárez2,3*, Rosana Pelayo, PhD4* and Monica L. Guzman, PhD5

1Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
23Oncology Research Unit, Mexican Institute for Social Security, Mexico City, Mexico
3Molecular Biomedicine Program, CINVESTAV, Mexico City, Mexico
4Oncology Research Unit, Mexican Institute for Social Security, Mexico City, Mexico
5Division of Hematology and Medical Oncology, Department of Medicine and Department of Pharmacology, Weill Cornell Medical College, New York, NY

*signifies non-member of ASH